OVERVIEW

VIRTUAL PROGRAM
Columbia University Irving Medical Center invites you to join the leading educators from Columbia University, addressing an overview of high yield challenging scenarios in the management of IgA Nephropathy. The half-day course is designed to enhance the knowledge of healthcare professionals on the IgAN updates including pathogenesis (with particular emphasis on the Gut-Renal axis) , genetics, pathology and non-immunosuppresive and  immunosuppressive strategies. Through a combination of lectures and case-based presentations, this course will deliver up-to-date and cutting-edge information that can be directly integrated into clinical practice.

LEARNING OBJECTIVES

1. Discuss the basis of the pathogenesis of IgAN.
2. Define renal pathology patterns of IgAN, with emphasis on scoring systems.
3. Explain the management of IgAN using risk calculators, standard and novel therapies.

ACCREDITATION

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Columbia University. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Amedco Joint Accreditation #4008163.

Physicians (ACCME) Credit Designation Statement
Amedco LLC designates this live virtual activity for a maximum of 4.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.